Paetz; Jana

Patent Applications and Registrations

Patent applications and USPTO patent grants for Paetz; Jana.The latest application filed is for "pharmaceutical compositions comprising rivaroxaban".

Company Profile

0.10.38

Paetz; Jana - Bonn DE
Paetz; Jana - Moorenwies N/A DE
Paetz; Jana - City Bonn DE
Paetz; Jana - North Rhine-Westphalia DE
Paetz; Jana - Moorenweis DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Prasugrel in non-crystalline form and pharmaceutical composition thereof Grant 9,403,842 - Brueck , et al. August 2, 2	2016-08-02
Desfesoterodine in the form of a tartaric acid salt Grant 9,085,507 - Fischer , et al. July 21, 2	2015-07-21
Prasugrel in micronized, crystalline form and pharmaceutical composition thereof Grant 8,940,757 - Brueck , et al. January 27, 2	2015-01-27
Pharmaceutical Compositions Comprising Rivaroxaban App 20140319720 - Stefan; Ralph ; et al.	2014-10-30
Oral dosage form of deferasirox Grant 8,703,203 - Paetz , et al. April 22, 2	2014-04-22
Solid Composition Containing The Ingredient Rasagiline App 20130345310 - Rimkus; Katrin ; et al.	2013-12-26
Pharmaceutical composition comprising N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)e- thyl]amino]methyl]-quinazolinamine Grant 8,586,091 - Rimkus , et al. November 19, 2	2013-11-19
Pharmaceutical Compositions Comprising 5-chloro-n-(-methyl)-2-thiophencarboxamid App 20130281457 - Rimkus; Katrin ; et al.	2013-10-24
Dabigatran Etexilate-containing Pharmaceutical Composition App 20130149346 - Meergans; Dominique ; et al.	2013-06-13
Oral Dosage Form Of Deferasirox App 20130142871 - Paetz; Jana ; et al.	2013-06-06
Solid Tapentadol In Non-crystalline Form App 20130116333 - Paetz; Jana ; et al.	2013-05-09
Melt-granulated Fingolimod App 20130102683 - Paetz; Jana ; et al.	2013-04-25
Fingolimod In The Form Of A Solid Solution App 20130102682 - Paetz; Jana ; et al.	2013-04-25
Method Of Preparing An Oral Dosage Form Comprising Fingolimod App 20130095177 - Paetz; Jana ; et al.	2013-04-18
Dabigatran Etexilate-containing Oral Pharmaceutical Composition App 20130052262 - Brueck; Sandra ; et al.	2013-02-28
Prasugrel In Micronized, Crystalline Form And Pharmaceutical Composition Thereof App 20130035355 - Brueck; Sandra ; et al.	2013-02-07
Oral Form Of Administration Comprising Entecavir App 20120308652 - Stumm; Daniela ; et al.	2012-12-06
Melt-granulated Cinacalcet App 20120270949 - Paetz; Jana ; et al.	2012-10-25
Pharmaceutical Compositions Comprising Rivaroxaban App 20120231076 - Stefan; Ralph ; et al.	2012-09-13
Prasugrel In Non-crystalline Form And Pharmaceutical Composition Thereof App 20120149727 - Brueck; Sandra ; et al.	2012-06-14
Desfesoterodine In The Form Of A Tartaric Acid Salt App 20120128773 - Fischer; Dirk ; et al.	2012-05-24
Dry Processing Of Retigabine App 20120122973 - Paetz; Jana ; et al.	2012-05-17
Solid Retigabine In Non-crystalline Form App 20120053238 - Paetz; Jana ; et al.	2012-03-01
Intermediate And Oral Administrative Formats Containing Lenalidomide App 20120046315 - Rimkus; Katrin ; et al.	2012-02-23
Amorphous Ambrisentan App 20120022087 - Rimkus; Kathrin ; et al.	2012-01-26
Pharmaceutical Composition Comprising N-[3-chloro-4-[(3-fluorophenyl)methoxy] Phenyl]-6-[5[[[2-(methylsulfonyl) Ethyl]amino]methyl]-2-furyl]-4- Quinazolinamine App 20120015965 - Rimkus; Katrin ; et al.	2012-01-19
Compacted Cinacalcet App 20120009258 - Rimkus; Kathrin ; et al.	2012-01-12
Solid Composition Containing The Ingredient Rasagiline App 20110313050 - Rimkus; Katrin ; et al.	2011-12-22
Pharmaceutical Composition Comprising N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)e- Thyl]amino]methyl]-2-furyl]-4- Quinazolinamine App 20110305762 - Rimkus; Katrin ; et al.	2011-12-15
Pharmaceutical Compositions Comprising 5-chloro-n-(-methyl)-2-thiophencarboxamid App 20110300214 - Rimkus; Katrin ; et al.	2011-12-08
Pharmaceutical Compositions With Modified Release Properties Comprising 5-chloro-n-(-methyl)-2-thiophencarboxamid App 20110189279 - Rimkus; Katrin ; et al.	2011-08-04
Pharmaceutical Formulation For Lowering Pulmonary Blood Pressure App 20110189243 - Rimkus; Katrin ; et al.	2011-08-04
Directly Pressed Aliskiren Tablets App 20110165235 - Paetz; Jana ; et al.	2011-07-07
Pharmaceutical Compositions Comprising N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylide- Ne)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide App 20100310668 - Paetz; Jana ; et al.	2010-12-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.